Answer
Stelara (ustekinumab) 130 mg concentrate for infusion treats adults with moderately to severely active Crohn’s disease or ulcerative colitis after inadequate response, loss of response or intolerance to conventional therapy, a TNF antagonist (Crohn’s disease) or a biologic (ulcerative colitis).
Sources for this answer
- STELARA 130 mg concentrate for solution for infusionJanssen-Cilag Ltd (a Johnson & Johnson Company) · emc · SmPC §4.1 Therapeutic Indications · Version 25Document updated
Sources checked